|Bid||100.57 x 1300|
|Ask||0.00 x 0|
|Day's Range||101.37 - 103.91|
|52 Week Range||79.12 - 112.97|
|PE Ratio (TTM)||20.53|
|Earnings Date||Oct 19, 2017|
|Dividend & Yield||1.80 (1.71%)|
|1y Target Est||112.36|
Quest Diagnostics Inc NYSE:DGX
Myriad (MYGN) presenting positive riskScore data at the NSGC conference in Columbus, OH buoys optimism. Notably, with riskScore the company intends to boost its myRisk Hereditary Cancer test suite.
MADISON, N.J., Sept. 14, 2017 /PRNewswire/ -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, was named for the thirteenth consecutive year in the North America Dow Jones Sustainability Index (DJSI) and for a fourteenth year in the World DJSI. Quest Diagnostics was one of only nine Health Care Equipment and Services companies listed on the Dow Jones Sustainability North America Index and one of only twelve companies listed on the Dow Jones Sustainability World Index in the same category. Over last year, the company improved its percentile ranking in the areas of Risk & Crisis Management and Human Capital Development.